These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 14599013)

  • 1. 4-Fluorinated L-lysine analogs as selective i-NOS inhibitors: methodology for introducing fluorine into the lysine side chain.
    Hallinan EA; Kramer SW; Houdek SC; Moore WM; Jerome GM; Spangler DP; Stevens AM; Shieh HS; Manning PT; Pitzele BS
    Org Biomol Chem; 2003 Oct; 1(20):3527-34. PubMed ID: 14599013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Fluorinated L-lysine analogues as selective induced nitric oxide synthase inhibitors.
    Hallinan EA; Hagen TJ; Bergmanis A; Moore WM; Jerome GM; Spangler DP; Stevens AM; Shieh HS; Manning PT; Pitzele BS
    J Med Chem; 2004 Feb; 47(4):900-6. PubMed ID: 14761191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological characterization of L-N(6)-(1-iminoethyl)lysine 5-tetrazole-amide, a prodrug of a selective iNOS inhibitor.
    Hallinan EA; Tsymbalov S; Dorn CR; Pitzele BS; Hansen DW; Moore WM; Jerome GM; Connor JR; Branson LF; Widomski DL; Zhang Y; Currie MG; Manning PT
    J Med Chem; 2002 Apr; 45(8):1686-9. PubMed ID: 11931623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural characterization and kinetics of nitric-oxide synthase inhibition by novel N5-(iminoalkyl)- and N5-(iminoalkenyl)-ornithines.
    Bretscher LE; Li H; Poulos TL; Griffith OW
    J Biol Chem; 2003 Nov; 278(47):46789-97. PubMed ID: 12960153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of renal disease in MRL/lpr mice by pharmacologic inhibition of inducible nitric oxide synthase.
    Reilly CM; Farrelly LW; Viti D; Redmond ST; Hutchison F; Ruiz P; Manning P; Connor J; Gilkeson GS
    Kidney Int; 2002 Mar; 61(3):839-46. PubMed ID: 11849435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective iNOS inhibition attenuates acetylcholine- and bradykinin-induced vasoconstriction in lipopolysaccharide-exposed rat lungs.
    Fischer LG; Horstman DJ; Hahnenkamp K; Kechner NE; Rich GF
    Anesthesiology; 1999 Dec; 91(6):1724-32. PubMed ID: 10598616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorination Effects on NOS Inhibitory Activity of Pyrazoles Related to Curcumin.
    Nieto CI; Cabildo MP; Cornago MP; Sanz D; Claramunt RM; Torralba MC; Torres MR; Elguero J; García JA; López A; Acuña-Castroviejo D
    Molecules; 2015 Aug; 20(9):15643-65. PubMed ID: 26343623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of inducible nitric oxide synthase inactivation by aminoguanidine and L-N6-(1-iminoethyl)lysine.
    Bryk R; Wolff DJ
    Biochemistry; 1998 Apr; 37(14):4844-52. PubMed ID: 9538001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the effects of L-NAME, 7-NI and L-NIL on carrageenan-induced hindpaw oedema and NOS activity.
    Handy RL; Moore PK
    Br J Pharmacol; 1998 Mar; 123(6):1119-26. PubMed ID: 9559895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective iNOS inhibition prevents hypotension in septic rats while preserving endothelium-dependent vasodilation.
    Strunk V; Hahnenkamp K; Schneuing M; Fischer LG; Rich GF
    Anesth Analg; 2001 Mar; 92(3):681-7. PubMed ID: 11226101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of NO synthase inhibitors on the synovial microcirculation in the mouse knee joint.
    Veihelmann A; Krombach F; Refior HJ; Messmer K
    J Vasc Res; 1999; 36(5):379-84. PubMed ID: 10559678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-N6-(1-iminoethyl)-lysine (L-NIL) but not S-methylisothiourea sulphate (SMT) displays selectivity towards NOS-2.
    Chłopicki S; Olszanecki R; Jakubowski A; Lomnicka M; Gryglewski RJ
    Pol J Pharmacol; 1999; 51(5):443-7. PubMed ID: 10817546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural requirements for human inducible nitric oxide synthase substrates and substrate analogue inhibitors.
    Grant SK; Green BG; Stiffey-Wilusz J; Durette PL; Shah SK; Kozarich JW
    Biochemistry; 1998 Mar; 37(12):4174-80. PubMed ID: 9521739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorinated dihydroquinolines as potent n-NOS inhibitors.
    Jaroch S; Rehwinkel H; Hölscher P; Sülzle D; Burton G; Hillmann M; McDonald FM; Miklautz H
    Bioorg Med Chem Lett; 2004 Feb; 14(3):743-6. PubMed ID: 14741281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury.
    Chatterjee PK; Patel NS; Kvale EO; Cuzzocrea S; Brown PA; Stewart KN; Mota-Filipe H; Thiemermann C
    Kidney Int; 2002 Mar; 61(3):862-71. PubMed ID: 11849439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of chronic treatment with the inducible nitric oxide synthase inhibitor N-iminoethyl-L-lysine or with L-arginine on progression of coronary and aortic atherosclerosis in hypercholesterolemic rabbits.
    Behr-Roussel D; Rupin A; Simonet S; Bonhomme E; Coumailleau S; Cordi A; Serkiz B; Fabiani JN; Verbeuren TJ
    Circulation; 2000 Aug; 102(9):1033-8. PubMed ID: 10961969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inducible NOS inhibition, eicosapentaenoic acid supplementation, and angiotensin II-induced renal damage.
    Theuer J; Shagdarsuren E; Muller DN; Kaergel E; Honeck H; Park JK; Fiebeler A; Dechend R; Haller H; Luft FC; Schunck WH
    Kidney Int; 2005 Jan; 67(1):248-58. PubMed ID: 15610248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-dependent aggravation or attenuation of lipopolysaccharide-induced gastric injury by nitric oxide synthase inhibition.
    Suliburk JW; Helmer KS; Kennison SD; Mercer DW; Robinson EK
    J Surg Res; 2005 Dec; 129(2):265-71. PubMed ID: 16026802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics.
    Hansel TT; Kharitonov SA; Donnelly LE; Erin EM; Currie MG; Moore WM; Manning PT; Recker DP; Barnes PJ
    FASEB J; 2003 Jul; 17(10):1298-300. PubMed ID: 12738811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of inducible nitric oxide synthase enhances intraglomerular coagulation in chronic anti-Thy 1 nephritis.
    Westenfeld R; Gawlik A; de Heer E; Kitahara M; Abou-Rebyeh F; Floege J; Ketteler M
    Kidney Int; 2002 Mar; 61(3):834-8. PubMed ID: 11849434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.